Saffron Mood Meta-analysis: What the Evidence Says

Quick Answer

Saffron Mood Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• It is often considered as one of the most intense experiences a woman may endure.Consequently, the fear of this pain contributes to an increased preference for cesarean delivery.It triggers increased fear and anxiety, which signals the sympathetic nervous system into a fight-or-flight response. [Alshdefat Aisha (2026); evidence level 4]
• , Medical conditions associated with prolonged labor increase the maternal mortality rate, particularly in developing countries. [Alshdefat Aisha (2026); evidence level 4]
• Depression is a leading cause of disability worldwide and is characterised by sustained low mood, anhedonia, anergia, and a range of associated cognitive and somatic symptoms . [Muacevic Alexander (2026); evidence level 4]
• This literature review summarises key randomised controlled trials (RCTs), meta-analyses, safety data, dosing patterns, and guideline positioning for saffron in depressive disorders, with emphasis on adult major depressive disorder (MDD) and related depressive symptomatology. [Muacevic Alexander (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For saffron mood meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Alshdefat Aisha (2026). Saffron and Pregnancy: Cultural Practices, Beliefs, and Safety Evidence: An Integrative Review. DOI: 10.1177/2515690X261455162. PMCID: PMC13213103. PMID: 42186868. License: https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/ https://us.sagepub.co.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13213103/
• Muacevic Alexander (2026). The Role of Saffron in the Treatment of Depression: A Literature Review. DOI: 10.7759/cureus.104594. PMCID: PMC13044667. PMID: 41939549. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13044667/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.